Finding Cures For Tropical Diseases: Is Open Source An Answer?
...t any discovery would beoff patent. An open-source license would keep all discoveries freelyavailable to researchers and--eventually--manufacturers. The absence ofpatents, and the use of volunteer staff, would contain the costs ofdrug development.Ten years ago, say the authors, TDI would not have been feasib...Alaskan puzzles, monitoring provide insight about North Pacific salmon runs
...sed boats even bothered to fish and the value of a license to fish there has dropped from a high of $250,000 to perhaps $20,000. "Rather than maximizing the number of fish harvested, if you maximized the economic value of the catch, including fixed and variable costs, you might consider harvesting very diff...Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
...that Caliper has issued Affymetrix a non-exclusive license to use a portion of Caliper's microfluidics patent...fymetrix' GeneChip(R) microarray technologies. The license extends to the manufacture and sale of GeneChip brand products in all areas of application, includin...Chemicals in tattoo inks need closer scrutiny
...s-204.html. This effectively gives a tattoo artist license to inject whatever he or she deems appropriate under the skin, according to the researchers. "Tattoos are no longer limited to the rough and rowdy," says Haley Finley-Jones, an undergraduate chemistry student and lead author of the study. "With the ...Virginia Tech group adds tools to DNA-targeted anti-cancer drugs
..., a medical laser company in Canada that holds the license on the patented systems. ...Bad aftertaste? New sensory on/off switch may 'cure' bane of artificial sweetener search
..., a medical laser company in Canada that holds the license on the patented systems. ...Researchers develop new method for facile identification of proteins in bacterial cells
...s University is seeking partners who would like to license this patent-pending methodology. Inquiries may be directed to Deborah Alper at the Johns Hopkins Bloomberg School of Public Health at dalper@jhsph.edu or 443-287-0402. "Identification and Phenotypic Characterization of Sphingomonas wittichii Strain ...Compound might defeat African sleeping sickness, clinical trial beginning this month
...ug development effort, has an exclusive, worldwide license to DB289 and related compounds developed by the UNC-based scientific consortium for African sleeping sickness and other devastating diseases such as TB, which together affect millions of people annually," Tidwell said. "Besides DB289, several potenti...Experimental shingles vaccine proves effective in nationwide study
... April 25, Merck announced that it had submitted a license application to the Food and Drug Administration for the zoster vaccine. If approved for use, the research team estimates the vaccine could prevent 250,000 cases of shingles that occur in the United States each year and significantly reduce the severi...Discarded placentas deliver researchers promising cells similar to embryonic stem cells
...ty patent policy, Drs. Strom and Miki will receive license proceeds. Both have served as paid consultants and hold equity in Stemnion. The research was supported by the Alpha-1 Foundation and the National Institute of Diabetes and Digestive and Kidney Diseases, a part of the National Institutes of Health. I...Vaginal gel may provide a new approach to HIV prevention
...MS) today announced that they have signed separate license agreements with the International Partnership for ...ach will grant the non-profit group a royalty-free license to develop, manufacture and distribute their compounds for use as microbicides in resource-poor coun...Compound from marine bacteria shows potential as multiple myeloma therapy
... tests. Nereus Pharmaceuticals holds an exclusive license to the compound for drug development. Experiments with NPI-0052 began at Dana-Farber in 2003, said Dharminder Chauhan, PhD, lead author of the paper along with Laurence Catley, PhD. When added to cells from patients whose disease was resistant to ...Researchers make long DNA 'wires' for future medical and electronic devices
...nd and control this process." The university will license the technology for further development. Lee and Guan are working on their first application ?building the wires into sensors for detecting disease biomarkers. In the meantime, they are collaborating with researchers in the Department of Electrical an...Human trial proves ricin vaccine safe, induces neutralizing antibodies; further tests planned
...eminate." DOR BioPharma has received an exclusive license for RiVax and is developing large scale manufacturing processes. DOR officials hope to produce a large stockpile for more advanced human clinical testing, product licensing and potential purchases from the U.S. government and other interested parties...Pacific Islands paradise protected
...ati government for the foregone commercial fishing license revenues. The plan allows for subsistence fishing by resident communities and other sustainable economic development in designated zones of the protected area. In creating the protected area, the Republic of Kiribati took a significant step toward m...Ebola DNA vaccine produces immune responses in all fully vaccinated volunteers in Phase 1 trial
...strains of Ebola. Vical has secured a nonexclusive license from the NIH to proprietary gene sequences used in the vaccine. "The high rates of immune responses at all dose levels in this initial human Ebola vaccine study support continued development of this vaccine and further evaluation of our technology ...Federal testing for mad cow disease a failure, law review editor says
...ngress should pass legislation forcing the USDA to license BSE tests to ranchers and slaughterhouses. "The USDA should create standards for testing conditions and requirements, and promulgate an application process with objective criteria for private producers. A standard testing regime would enable private ...Flu shot effective against drifted influenza, nasal spray vaccine less so
...tus of epidemiology. MedImmune produces it under a license with the University. Monto's research team is conducting a randomized, double-blind, placebo-controlled three-year trial with National Institutes of Health funding in which the two vaccines are being compared head-to-head and against a placebo. Pr...Chemical tests of cell growth enter third dimension
...echnology further. The university is expecting to license both technologies. ...Columbia University licenses next-generation DNA sequencing technology
...unces today that it recently executed an exclusive license agreement for a next generation DNA sequencing tec...n, Chief Executive Officer at IBS. "Completing the license was a key step in uniting Dr. Ju's seminal sequencing chemistry and IBS's molecular biology and engi...